FDA sued over antibiotics in farm feed

By Admin
The US Food and Drug Association (FDA) is having a federal lawsuit filed against by a coalition of consumer groups who say that the use of human antibi...

The US Food and Drug Association (FDA) is having a federal lawsuit filed against by a coalition of consumer groups who say that the use of human antibiotics in animal feed creates dangerous superbugs.

The groups allege that the practice of including penicillin and tetracycline in the feed of healthy animals could result in the rise of bacteria and superbugs that are resistant to antibiotics in people.

 The drugs are usually added to the feeds of cows, pigs, chickens and other livestock and although the dose is so low it is unable to treat diseases, it leaves surviving bacteria stronger and more able to able to resist them.

To read the latest edition of Healthcare Global, click here

The lawsuit claims that the FDA discovered the risks of adding antibiotics to animal feed in 1977 and although the health agency was required to act on its findings the FDA “failed to take any action to protect human health,” the groups said in a statement.

Groups included in the coalition are the Food Animal Concerns Trust, Natural Resources Defence Council (NRDC), Centre for Science in the Public Interest, Public Citizen, and the Union of Concerned Scientists.

Their aim is to “compel the FDA to take action on the agency's own safety findings, withdrawing approval for most non-therapeutic uses of penicillin and tetracycline in animal feed.”

The executive director of NRDC, Peter Lehner, said in an interview: “Accumulating evidence shows that antibiotics are becoming less effective, while our grocery store meat is increasingly laden with drug-resistant bacteria.”

However, the FDA believes that when used properly, the drugs could play a key role against harmful bugs.

Share

Featured Articles

The Merck Group: Pharma's History & Innovation in India

Welcome back to part two of our exploration of The Merck Group's history and investment in China and India, with this part focusing on innovation in India

How CVS Health is Rising to the Omnichannel Challenge

US healthcare company CVS Health is reshaping its supply chain to meet the omnichannel needs of its customers

Kinaxis: Pharma Seeing Euro-wide Supply Chain Challenges

Supply chain specialist Kinaxis says UK pharma still recovering from Brexit and pandemic, and that Europe also seeing medicines value chain problems

Healthcare Digital Transformations Stymied by Data Silos

Digital Healthcare

McKinsey: Brain Health Underfunding 'a Global Concern'

Digital Healthcare

Endometriosis Linked to Heart Attacks & Strokes

Medical Devices & Pharma